4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride

CAS : 74226-22-5

Ref. 3D-ZCA22622

Informations sur le produit

• Nom: 4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride
• Synonymes: 1-[2-(4-Carboxyphenoxy)ethyl]imidazole monohydrochloride, 4-[2-(1H-imidazol-1-yl)ethoxy]benzoic acid hydrochloride (1:1), Benzoic acid, 4-[2-(1H-imidazol-1-yl)ethoxy]-, hydrochloride (1:1), Benzoic acid, 4-[2-(1H-imidazol-1-yl)ethoxy]-, monohydrochloride, Dazoxiben hydrochloride, Dazoxiben monohydrochloride, Uk 37248, Uk-37248-01

Description

4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride is a fatty acid synthetase inhibitor that inhibits the synthesis of long chain fatty acids. It was developed as a potential treatment for inflammatory bowel disease, but has not been studied in humans. 4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride has been shown to lower systolic blood pressure in rats and has been found to be non-toxic in animal toxicity studies at up to 1000 mg/kg per day. This drug also blocks the production of endothelin-A, which may have therapeutic benefits in experimental models of heart failure and chronic kidney disease.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 268.69 g/mol
• Formule: C₁₂H₁₃ClN₂O₃
• Degré de pureté: Min. 95%